Knight Therapeutics Inc. Exits Position in 60 Degrees Pharmaceuticals, Inc. (SXTP)

Knight Therapeutics Inc. has filed an Amendment No. 3 to its Schedule 13G regarding its holdings in 60 Degrees Pharmaceuticals, Inc. (SXTP). This filing serves as an official exit filing, indicating that as of March 31, 2026, the reporting person no longer beneficially owns any shares of the issuer's common stock. Previously, Knight Therapeutics held a position in the company's common stock, par value $0.0001 per share. The filing confirms that the reporting person has zero shares, resulting in a 0% ownership stake. The document was signed by Samira Sakhia on May 15, 2026, and specifies that the securities were not held for the purpose of changing or influencing the control of the issuer. This complete divestment marks the end of Knight Therapeutics' status as a significant shareholder in the Washington D.C.-based pharmaceutical company.